UniProt/SwissProt ID: | CDK2_HUMAN |
Description: | cyclin-dependent kinase 2 [Source:HGNC Symbol;Acc:1771] |
Location: | chr12 q13.2 |
Node attribute: | substrate; kinase; gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T14 | KIGEGtYGVVY | Pkinase | PhosphoSitePlus; SysPTM |
Y19 | TYGVVyKARNK | phosphoELM; RegPhos | |
T160 | PVRTYtHEVVT | Pkinase | PhosphoSitePlus |
T160 | PVRTYtHEVTR | HPRD | |
Y15 | IGEGTyGVVYK | Wee1 | RegPhos; SysPTM |
Y19 | TYGVVyKARNK | CDK2 | HPRD |
S46 | TEGVPsTAIRE | Pkinase | PhosphoSitePlus; SysPTM |
Y15 | IGEGTyGVVYK | Pkinase | PhosphoSitePlus; SysPTM |
T137 | NLLINtEGAIK | Pkinase | PhosphoSitePlus |
T158 | GVPVRtYTHEV | Pkinase | PhosphoSitePlus; SysPTM |
T158 | GVPVRtYTHEV | HPRD; SysPTM | |
T165 | THEVVtLWYRA | Pkinase | PhosphoSitePlus |
T14 | KIGEGtYGVVY | HPRD; phosphoELM; RegPhos; SysPTM | |
T160 | PVRTYtHEVVT | CDK7 | HPRD; RegPhos |
T39 | KIRLDtETEGV | Pkinase | PhosphoSitePlus |
Y168 | VVTLWyRAPEI | Pkinase | PhosphoSitePlus |
Y159 | VPVRTyTHEVV | HPRD; phosphoELM | |
Y15 | IGEGTyGVVYK | HPRD; phosphoELM; RegPhos; SysPTM | |
Y159 | VPVRTyTHEVV | Pkinase | PhosphoSitePlus |
Y179 | LLGCKyYSTAV | Pkinase | PhosphoSitePlus |
S46 | TEGVPsTAIRE | HPRD; SysPTM | |
Y19 | TYGVVyKARNK | Pkinase | PhosphoSitePlus |
Y15 | IGEGTyGVVYK | WEE1 | RegPhos; SysPTM |
T39 | KIRLDtETEGV | HPRD | |
Y15 | IGEGTyGVVYK | WEE1 | HPRD; SysPTM |
T160 | PVRTYtHEVVT | CCRK | RegPhos |
T160 | PVRTYtHEVVT | HPRD; phosphoELM; RegPhos | |
T160 | PVRTYtHEVVT | CDK20 | HPRD |
T160 | PVRTYtHEVVT | DDR1(CAK | RegPhos |
Dephosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T160 | GVPVRTYtHEVTRRA | PPM1B | HPRD |
T160 | GVPVRTYtHEVVTLW | PPM1B | HPRD |
Y15 | EKIGEGTyGVVYKAR | CDC25A | HPRD |
T14 | VEKIGEGtYGVVYKA | CDC25A | HPRD |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000266970 | F109L | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000243067 | F109L | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000266970 | P45L | Greenman2007, HPI | Neoplasms by Histologic Type | 16618716, 17344846, 18428421 |
ENSP00000266970 | P45L | Greenman2007 | Central Nervous System Neoplasms | 16618716, 17344846, 18428421 |
Differential expressed protein |
CDK2_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
Site | Motif | Peptide | Cancer name | Pubmed | Source |
---|---|---|---|---|---|
Y15 | Pkinase | EKIGEGTyGVVYKAR | cholangiocellular carcinoma | 21253578 | PhosphoSitePlus |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
CDK2_HUMAN | FOXM1_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | NPM_HUMAN | kinase -> substrate | HPRD; RegPhos |
HIPK1_HUMAN | CDK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
CDK2_HUMAN | KITH_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | MCM4_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CDN1B_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | PP1A_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | MYBB_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | TSYL2_HUMAN | kinase -> substrate | HPRD |
CDK2_HUMAN | CP110_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | PTHR_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | FZR_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | COIL_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | TFDP1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | P53_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | RBL1_HUMAN | kinase -> substrate | RegPhos |
CDK7_HUMAN | CDK2_HUMAN | kinase -> substrate | HPRD; RegPhos; NetPath |
WEE1_HUMAN | CDK2_HUMAN | kinase -> substrate | HPRD |
CDK2_HUMAN | CDX2_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CDK7_HUMAN | kinase -> substrate | RegPhos |
ZAGL2_HUMAN | CDK2_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | PTN2_HUMAN | kinase -> substrate | HPRD |
CDK2_HUMAN | KAP0_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CDC7_HUMAN | kinase -> substrate | HPRD |
AAPK1_HUMAN | CDK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
CDK2_HUMAN | PRC1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CDK2_HUMAN | kinase -> substrate | HPRD |
CDK2_HUMAN | CABL1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | RBL2_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | ID3_HUMAN | kinase -> substrate | HPRD; RegPhos; NetPath |
CDK2_HUMAN | CDC6_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | ORC1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | SF3B1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | UBE2A_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | TFDP2_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | PRGR_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CDN1A_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | NPAT_HUMAN | kinase -> substrate | RegPhos |
CDK20_HUMAN | CDK2_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | UBF1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | CCNE1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | RB_HUMAN | kinase -> substrate | RegPhos; NetPath |
CDK2_HUMAN | HIRA_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | NFYA_HUMAN | kinase -> substrate | HPRD |
CDK2_HUMAN | P73_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | SMAD3_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | ESR1_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | ID2_HUMAN | kinase -> substrate | HPRD; RegPhos; NetPath |
DDR1_HUMAN | CDK2_HUMAN | kinase -> substrate | RegPhos |
CDK2_HUMAN | MYOD1_HUMAN | kinase -> substrate | HPRD; RegPhos |
CDK2_HUMAN | BRCA1_HUMAN | kinase -> substrate | RegPhos |
MPIP1_HUMAN | CDK2_HUMAN | phosphatase -> substrate | KEGG |
PPM1B_HUMAN | CDK2_HUMAN | phosphatase -> substrate | HPRD |
SP1_HUMAN | CDK2_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa05169 | Epstein-Barr virus infection |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa05222 | Small cell lung cancer |
hsa05168 | Herpes simplex infection |
hsa04115 | p53 signaling pathway |
hsa04110 | Cell cycle |
hsa05203 | Viral carcinogenesis |
hsa05215 | Prostate cancer |
hsa05162 | Measles |
hsa04114 | Oocyte meiosis |
hsa05200 | Pathways in cancer |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0045893 | positive regulation of transcription, DNA-dependen | IEA | biological_process |
GO:0016772 | transferase activity, transferring phosphorus-cont | IEA | molecular_function |
GO:0051301 | cell division | IEA | biological_process |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage chec | TAS | biological_process |
GO:0000084 | S phase of mitotic cell cycle | TAS | biological_process |
GO:0007126 | meiosis | TAS | biological_process |
GO:0051298 | centrosome duplication | TAS | biological_process |
GO:0005667 | transcription factor complex | IEA | cellular_component |
GO:0000278 | mitotic cell cycle | TAS | biological_process |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0000216 | M/G1 transition of mitotic cell cycle | TAS | biological_process |
GO:0051439 | regulation of ubiquitin-protein ligase activity in | TAS | biological_process |
GO:0006813 | potassium ion transport | IEA | biological_process |
GO:0005813 | centrosome | TAS | cellular_component |
GO:0000085 | G2 phase of mitotic cell cycle | TAS | biological_process |
GO:0030332 | cyclin binding | IEA | molecular_function |
GO:0005654 | nucleoplasm | TAS | cellular_component |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0000082 | G1/S transition of mitotic cell cycle | TAS | biological_process |
GO:0000086 | G2/M transition of mitotic cell cycle | NAS | biological_process |
GO:0006281 | DNA repair | IEA | biological_process |
GO:0000781 | chromosome, telomeric region | IEA | cellular_component |
GO:0004713 | protein tyrosine kinase activity | IEA | molecular_function |
GO:0005634 | nucleus | IDA | cellular_component |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0060968 | regulation of gene silencing | IDA | biological_process |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0031145 | anaphase-promoting complex-dependent proteasomal u | TAS | biological_process |
GO:0005829 | cytosol | TAS | cellular_component |
GO:0006977 | DNA damage response, signal transduction by p53 cl | TAS | biological_process |
GO:0000806 | Y chromosome | IEA | cellular_component |
GO:0004672 | protein kinase activity | IEA | molecular_function |
GO:0035173 | histone kinase activity | IDA | molecular_function |
GO:0007067 | mitosis | IEA | biological_process |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | IEA | cellular_component |
GO:0016301 | kinase activity | IEA | molecular_function |
GO:0007596 | blood coagulation | TAS | biological_process |
GO:0007049 | cell cycle | IEA | biological_process |
GO:0007265 | Ras protein signal transduction | IEP | biological_process |
GO:0004693 | cyclin-dependent protein kinase activity | IEA | molecular_function |
GO:0015030 | Cajal body | IDA | cellular_component |
GO:0016572 | histone phosphorylation | IDA | biological_process |
GO:0071732 | cellular response to nitric oxide | TAS | biological_process |
GO:0008284 | positive regulation of cell proliferation | IDA | biological_process |
GO:0000075 | cell cycle checkpoint | TAS | biological_process |
GO:0005768 | endosome | IDA | cellular_component |
GO:0005737 | cytoplasm | IDA | cellular_component |
GO:0032298 | positive regulation of DNA-dependent DNA replicati | IEA | biological_process |
GO:0006468 | protein phosphorylation | IEA | biological_process |
GO:0000805 | X chromosome | IEA | cellular_component |
GO:0006260 | DNA replication | TAS | biological_process |
GO:0046872 | metal ion binding | IEA | molecular_function |
GO:0000793 | condensed chromosome | IEA | cellular_component |